Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Blood Advances
|
March 27, 2024
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease
Lauren E Merz, Duaa AbdelHameid, Dareen M Kanaan, et al.
The Lancet. Haematology
|
November 5, 2025
Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications
Omid Seidizadeh, Ferdows Atiq, Nathan T Connell, et al.
Anti-Cancer Drugs
|
August 11, 2018
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization management
Eytan Ben-Ami, Maria C Castells, Nathan T Connell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 27, 2022
Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience
Evan C Chen, William Gibson, Paula Temoczko, et al.
American Journal of Hematology
|
August 4, 2016
Factoring in the missing link
Nilay Sethi, Reza Sedighi Manesh, Adam Sperling, et al.
American Journal of Clinical Pathology
|
December 3, 2020
Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection
Olga Pozdnyakova, Nathan T Connell, Elisabeth M Battinelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 16, 2022
von Willebrand disease (VWD) and BATs: How do they connect and why should I care?
Leonard A Valentino, Marci L Hardy, Paula James, et al.
JAAD Case Reports
|
April 8, 2022
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
Amrita Goyal, Damodaran Narayanan, Waihay Wong, et al.
Therapeutic Advances in Hematology
|
April 8, 2026
Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?
Robert F Sidonio, Fernando F Corrales-Medina, Jill M Johnsen, et al.
Critical Pathways in Cardiology
|
May 17, 2019
Andexanet Alfa (Andexxa) Formulary Review
Nahal Beik, Prabashni Reddy, Katelyn W Sylvester, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Blood Advances
|
March 27, 2024
Anticoagulation and antiplatelet agent use among patients with von Willebrand disease and cardiac disease
Lauren E Merz, Duaa AbdelHameid, Dareen M Kanaan, et al.
The Lancet. Haematology
|
November 5, 2025
Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications
Omid Seidizadeh, Ferdows Atiq, Nathan T Connell, et al.
Anti-Cancer Drugs
|
August 11, 2018
Imatinib-induced drug reaction with eosinophilia and systemic symptoms in solid tumors: a patient with dermatofibrosarcoma protuberans and successful desensitization management
Eytan Ben-Ami, Maria C Castells, Nathan T Connell, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 27, 2022
Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience
Evan C Chen, William Gibson, Paula Temoczko, et al.
American Journal of Hematology
|
August 4, 2016
Factoring in the missing link
Nilay Sethi, Reza Sedighi Manesh, Adam Sperling, et al.
American Journal of Clinical Pathology
|
December 3, 2020
Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection
Olga Pozdnyakova, Nathan T Connell, Elisabeth M Battinelli, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
March 16, 2022
von Willebrand disease (VWD) and BATs: How do they connect and why should I care?
Leonard A Valentino, Marci L Hardy, Paula James, et al.
JAAD Case Reports
|
April 8, 2022
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
Amrita Goyal, Damodaran Narayanan, Waihay Wong, et al.
Therapeutic Advances in Hematology
|
April 8, 2026
Prophylaxis for von Willebrand disease: Is it time for parity with established practice in hemophilia A?
Robert F Sidonio, Fernando F Corrales-Medina, Jill M Johnsen, et al.
Critical Pathways in Cardiology
|
May 17, 2019
Andexanet Alfa (Andexxa) Formulary Review
Nahal Beik, Prabashni Reddy, Katelyn W Sylvester, et al.
Page
of 9